AMANDA GEORGE: Open Payments
NPI 1619152139 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 95 payments from 17 companies in 2025. Trend: 2023 $2,842 · 2024 $2,848 · 2025 $1,881
Food & beverage: $1,881
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 34 | $666 |
| ABBVIE INC. | 15 | $286 |
| Teva Pharmaceuticals USA, Inc. | 12 | $213 |
| Amneal Pharmaceuticals LLC | 10 | $180 |
| MDD US Operations, LLC | 8 | $174 |
| Merz Pharmaceuticals, LLC | 3 | $71 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
| Lilly USA, LLC | 2 | $34 |
| Cala Health, Inc. | 1 | $34 |
| Boston Scientific Corporation | 1 | $27 |
Products named: INGREZZA, AUSTEDO XR, VYALEV, CREXONT, QULIPTA, Xeomin, Gocovri, Dysport.
Industry payments across TX — which companies pay providers there.
